ArticleCancer causes & control : CCC2019

CYP2D6-inhibiting medication use and inherited CYP2D6 variation in relation to adverse breast cancer outcomes after tamoxifen therapy.

Sophie E Mayer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.